
1511PClinical implication of multiplex IHC and serologic biomarkers on hyperprogression in NSCLC patients receiving immune checkpoint blockers in real world
Kim, J, Kim, S, Kang, J H, Chun, S, Kim, S-YVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz260.033
Date:
October, 2019
Fichier:
PDF, 89 KB
2019